Bio Pharma Dive
SEPTEMBER 24, 2021
The suits allege an agreement between Merck and a generic manufacturer kept low-cost versions of the drugmaker's widely used Zetia off the market for years.
World of DTC Marketing
SEPTEMBER 24, 2021
SUMMARY: If I were to ask you, “what type of company is Biogen?” what would be your response? I tried asking that of several colleagues in the industry, and they couldn’t come up with an answer. Biogen has lost its way and is in desperate need of a corporate rebranding. This week two colleagues, who worked at Biogen, left the company because they knew that the ax was coming after the failure of Aduhelm.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
SEPTEMBER 24, 2021
The U.S. health department asked its inspector general to review the refusals of six drugmakers to offer discounts to safety net hospitals through community pharmacy partnerships.
Scienmag
SEPTEMBER 24, 2021
Dr. Daniel Pauly is the world’s most-cited fisheries scientist, but life for the UBC professor has been far from easy. The biracial son of a French woman and an American GI, he was born in Paris and kidnapped as a child to be a live-in servant for a Swiss family. He escaped to Germany at […].
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharma Times
SEPTEMBER 24, 2021
Trial will test if radium-223 plus avelumab can improve outcomes for metastatic breast cancer patients
pharmaphorum
SEPTEMBER 24, 2021
Targeting people for COVID-19 vaccination using contract-tracing apps could be a shortcut to achieving herd immunity in the population using fewer doses, according to Canadian researchers. According to Mark Penney, Yigit Yargic and colleagues from the Perimeter Institute for Theoretical Physics in Ontario, targeting vaccines to people who have more exposure than others is the most effective way to reduce transmission of SARS-CoV-2.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Scienmag
SEPTEMBER 24, 2021
CHAPEL HILL, N.C. – Scientists at Stanford University and the University of North Carolina at Chapel Hill have created a 3D-printed vaccine patch that provides greater protection than a typical vaccine shot. Credit: University of North Carolina at Chapel Hill CHAPEL HILL, N.C. – Scientists at Stanford University and the University of North Carolina at […].
Delveinsight
SEPTEMBER 24, 2021
Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. Factors such as population aging, lifestyle-modifiable risk factors, a decline in early-life infectious diseases, sedentary lifestyle, unhealthy food habits have resulted in the emergence of chronic diseases as a major global health threat. Among CDs, Chronic kidney disease (CKD) is particularly of huge concern owing to the increasing prevalence and severe financial implications it imparts leading to CVDs and
Pharma Times
SEPTEMBER 24, 2021
Results showed treatment with Crysvita reduces disease burden for patients
NY Times
SEPTEMBER 24, 2021
The expensive treatment, developed by the U.S. drug maker Regeneron and the Swiss biotech company Roche, has garnered attention as backstop for those who shun vaccines.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharma Times
SEPTEMBER 24, 2021
Research shows that the backlog has been ‘starkest’ in diagnostics
Outsourcing Pharma
SEPTEMBER 24, 2021
As COVID-19 and its variants continue their attack, the agency maintains its position of overseer and giver of advice on various treatments and vaccines.
Pharma Times
SEPTEMBER 24, 2021
Interim analysis showed significant improvement in radiographic progression-free survival
Outsourcing Pharma
SEPTEMBER 24, 2021
The cancer-centric pharma firm will work with the Houston-based cancer center to pinpoint new indications and biomarkers for its drug candidate, seclidemstat.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Pharma Times
SEPTEMBER 24, 2021
The winners of the 2021 International Clinical Researcher have been announced, find out who emerged victorious.
ECRG Media's Clinical Research Podcast
SEPTEMBER 24, 2021
Clinical Research Advice and Creating Clinical Research Tools Don't forget to Subscribe for new content! Merch: [link] Subscribe: [link] Email: eliteclinicalgroup@gmail.com Podcast: [link] [link] eliteclinicalgroup@gmail.com Watch: » Industry News: [link] All Videos: [link] Interview Recaps: [link] Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education Elite Clinical Research Group
Drug Patent Watch
SEPTEMBER 24, 2021
Annual Drug Patent Expirations for GENOSYL Genosyl is a drug marketed by Vero Biotech and is included in one NDA. There are nineteen patents protecting this drug. This drug has…. The post New patent for Vero Biotech drug GENOSYL appeared first on DrugPatentWatch - Make Better Decisions.
ECRG Media's Clinical Research Podcast
SEPTEMBER 24, 2021
These Tools Can Save 3 Hours On Site?? Don't forget to Subscribe for new content! Merch: [link] [link] eliteclinicalgroup@gmail.com Podcast: [link] [link] eliteclinicalgroup@gmail.com Watch: » Industry News: [link] All Videos: [link] Interview Recaps: [link] Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education Elite Clinical Research Group or ECRG for short is a content creating
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Drug Patent Watch
SEPTEMBER 24, 2021
Annual Drug Patent Expirations for IMVEXXY Imvexxy is a drug marketed by Therapeuticsmd Inc and is included in one NDA. It is available from one supplier. There are twelve patents…. The post New patent for Therapeuticsmd Inc drug IMVEXXY appeared first on DrugPatentWatch - Make Better Decisions.
ECRG Media's Clinical Research Podcast
SEPTEMBER 24, 2021
Clinical Research Advice and Creating Clinical Research Tools. Don't forget to Subscribe for new content! Merch: [link]. Subscribe: [link]. Email: eliteclinicalgroup@gmail.com Podcast: [link] [link] eliteclinicalgroup@gmail.com Watch: » Industry News: [link] All Videos: [link] Interview Recaps: [link] Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education.
Scienmag
SEPTEMBER 24, 2021
September is Spinal Cord Injury (SCI) Awareness month. According to the National Spinal Cord Injury Statistical Center, approximately 296,000 Americans are currently living with SCI, with around 17,900 new cases occurring each year. Credit: MUSC – Jessica Yurinko September is Spinal Cord Injury (SCI) Awareness month. According to the National Spinal Cord Injury Statistical Center, […].
ECRG Media's Clinical Research Podcast
SEPTEMBER 24, 2021
These Tools Can Save 3 Hours On Site?? Don't forget to Subscribe for new content! Merch: [link] [link] eliteclinicalgroup@gmail.com Podcast: [link] [link] eliteclinicalgroup@gmail.com Watch: » Industry News: [link] All Videos: [link] Interview Recaps: [link] Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
SEPTEMBER 24, 2021
Nearly half of adolescents and young adults with lingering symptoms of concussion suffer from an eye coordination disorder that causes blurred and double vision, headaches and difficulties concentrating. There is no proven method for treating the condition when it occurs after a head injury. Credit: NJIT Nearly half of adolescents and young adults with lingering symptoms […].
BioTech 365
SEPTEMBER 24, 2021
RGIS Continues to Deliver on Its International Growth Strategy With the Acquisition of WIS UK and WIS Mexico RGIS Continues to Deliver on Its International Growth Strategy With the Acquisition of WIS UK and WIS Mexico RGIS has acquired the … Continue reading →
Scienmag
SEPTEMBER 24, 2021
LOS ANGELES (September 24, 2021) — The Lundquist Institute (TLI) announced that it has received a generous $5 million, 5-year grant from the California Institute for Regenerative Medicine (CIRM) that will allow its PhD students, postdoctoral fellows and clinical fellows to pursue careers in stem cell biology and regenerative medicine. This award will also support […].
XTalks
SEPTEMBER 24, 2021
While the faces of those involved in cyberattacks are rarely revealed, high-tech criminals are highlighting the growing importance of food industry cybersecurity. Earlier this week, Iowa-based farm services firm NEW Cooperative Inc. experienced a cybersecurity incident that forced its systems offline before the US farm belt harvest. Luckily, the threat was contained, but the outcome could have been detrimental to agriculture. .
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
SEPTEMBER 24, 2021
This week the European University Alliance FORTHEM gathered in Mainz, Germany, for its first on-site meeting. Alongside the seven university partners from all over Europe, representatives of the FORTHEM partner cities and their chambers of commerce and industry were invited so that they could meet one another in person and exchange ideas. “We were extremely […].
pharmaphorum
SEPTEMBER 24, 2021
The process of discovering HCPs who are leading key opinion leaders (KOLs) in emerging and growing markets is not as straightforward as it is in other countries. When identifying KOLs within emerging markets, the need to conduct solid, primary research becomes paramount. Relying solely on the typical quantitative methodologies such as examining publications, citations, clinical trials, guideline development committees, etc., often yields low numbers of experts for several reasons.
Scienmag
SEPTEMBER 24, 2021
Specific and dynamic changes on electrocardiograms (EKGs) of hospitalized patients with COVID-19 or influenza can help predict a timeframe for worsening health and death, according to a new Mount Sinai study. The work, published in the September 24 online issue of the American Journal of Cardiology, shows that shrinking waveforms on these tests can be […].
pharmaphorum
SEPTEMBER 24, 2021
AstraZeneca and Merck & Co PARP inhibitor Lynparza is already used to treat prostate cancer associated with a specific genetic mutation, but could see the drug’s use broadened after a positive phase 3 trial. The results of the PROpel study showed that a combination of Lynparza (olaparib) and Johnson & Johnson’s hormonal therapy Zytiga (abiraterone acetate) given as a first-line treatment to an -all-comer’ population of men with metastatic castration-resistant prostate c
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
294 
Let's personalize your content